Clinical Trials Logo

Tobacco Smoke Pollution clinical trials

View clinical trials related to Tobacco Smoke Pollution.

Filter by:
  • None
  • Page 1

NCT ID: NCT05996029 Not yet recruiting - Passive Smoking Clinical Trials

A Joint Real-World Study of Digital Smoking Cessation Interventions

Start date: August 2023
Phase: N/A
Study type: Interventional

According to the "China Smoking Health Hazard Report 2020", the total number of smokers in China is estimated to be 350 million, of which 180 million are already addicted. In addition, more than 700 million nonsmokers are exposed to secondhand smoke and become passive smoking victims, among which the family is one of the main places of secondhand smoke exposure, and mothers and children are the most affected group. Passive smoking is a risk factor for spontaneous abortion in pregnant women and an important risk factor for the occurrence of gestational hypertension syndrome and pregnancy complications, and it also affects embryonic development with adverse pregnancy outcomes such as miscarriage, stillbirth, intrauterine growth retardation, preterm birth, immune deficiency, birth defects, and mental retardation. Helping smokers quit is the fundamental solution to reducing secondhand smoke exposure. The accessibility and effectiveness of traditional offline smoking cessation intervention services do not meet the needs of society. With the development of mobile communication technology, digital cessation such as SMS cessation, WeChat cessation, and APP cessation have emerged, which combine clinical cessation guidelines with software technology and present rich product features and interactive design, providing a new solution to expand the accessibility of clinical cessation interventions and address the problem of secondhand smoke exposure.We hope to explore the impact of different digital cessation tools and their combinations on reducing smoking prevalence and maternal tobacco exposure.

NCT ID: NCT00927264 Completed - Clinical trials for Tobacco Smoke Pollution

PRIDE: Preventing Respiratory Illnesses During Childhood Study

PRIDE
Start date: January 2009
Phase: N/A
Study type: Interventional

Environmental tobacco smoke (ETS0, also known as secondhand smoke, is the combination of smoke given off by the burning end of a tobacco product and the smoke exhaled by the smoker. Children exposed to ETS are at an increased risk of sudden infant death syndrome (SIDS), ear infections, colds, pneumonia, bronchitis and more severe asthma. ETS can also slow the growth of children's lungs and can cause them to cough, wheeze and fell breathless. The purpose of this study is to determine the effectiveness of a motivational interviewing-based program in reducing ETS exposure and improving lung health among children who are enrolled in a Head Start program and whose households include a smoker.

NCT ID: NCT00788996 Not yet recruiting - Clinical trials for Tobacco Smoke Pollution

Reduction of Environmental Tobacco Smoke (ETS) Exposure at Home: the BIBE Study

BIBE
Start date: January 2009
Phase: Phase 2
Study type: Interventional

Main objective: to determine the effectiveness of a brief opportunist educational performance directed to the parents who smoke -- inside the context of programmed visits of paediatrics in primary care -- to reduce the exposure of the babies to secondhand smoke (SHS) Secondary objectives: 1. Smoking reduction / quitting of the mother and/or the father 2. To determine the relationship between the level exposure to SHS and main related variables

NCT ID: NCT00757224 Not yet recruiting - Clinical trials for Tobacco Smoke Pollution

Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants

Start date: October 2008
Phase: N/A
Study type: Interventional

Parental smoking is associated with increased frequency of respiratory diseases including hospitalizations in infants. Study hypothesis: Parental education regarding the association between parental smoking and respiratory diseases in the infant, and guidance on ways to decrease smoke exposure by the infant, provided shortly after the infant is born, will decrease infants' morbidity.